Live Quote · OTCRBCLHealthcare· Medical - Pharmaceuticals

RBC Life Sciences, Inc.

$0.00 0.00%(+$0.00)
TickerSpark Score
57/100
Mixed
84
Valuation
40
Profitability
40
Growth
60
Health
60
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RBCL research report →

52-Week Range100% of range
Low
$0.00
Current
$0.00
High
$0.00
Company Overviewwww.rbclifesciences.com

About the company

RBC Life Sciences, Inc. manufactures, markets, and distributes nutritional supplements and personal care products. The company offers wellness products, weight loss, sports, and fitness products.

CEO
Michael J. Hartnett
IPO
2000
Employees
89
HQ
Irving, TX, US

Price Chart

+600.00% · this period
$0.00$0.00$0.00Jul 02Dec 31Jul 02
Valuation
Market Cap
$1.55K
P/E
-0.00
P/S
0.00
P/B
0.00
EV/EBITDA
5.84
Div Yield
0.00%
Profitability
Gross Margin
52.82%
Op Margin
-2.59%
Net Margin
-2.93%
ROE
-10.08%
ROIC
-8.78%
Growth & Income
Revenue
$25.77M · 5.78%
Net Income
$-756,284 · -1.95%
EPS
$-0.34 · 0.00%
Op Income
$-666,283
FCF YoY
100.15%
Performance & Tape
52W High
$0.00
52W Low
$0.00
50D MA
$0.00
200D MA
$0.00
Beta
-17.88
Avg Volume
2

Get TickerSpark's AI analysis on RBCL

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Dec 11, 12TYSINGER CYNTHIA Lother1,800
Coverage · RBCL

Our RBCL coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on RBCL yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate RBCL report →
Internal Compare

Similar companies

Peers in the same neighborhood.